Ginkgo Biloba Extract Efficacy Meta-Analysis for Hyperlipidemia

A meta-analysis of ten randomized controlled trials assesses Ginkgo biloba extract's efficacy and safety for hyperlipidemia. The analysis, sourced from PubMed, Wanfang, and CNKI up to December 31, 2024, compares effects on cholesterol and triglycerides against Western and Chinese medicine. Results include statistical significance for HDL improvement and age- and dose-specific effects.

Use Cases

• Evaluate Ginkgo biloba extract efficacy for hyperlipidemia based on pooled mean differences from RCTs.
• Compare herbal treatment outcomes against Western and proprietary Chinese medicine based on lipid profile metrics.
• Analyze age-specific therapeutic effects based on results for the 50-60 age group.
• Assess dose-response relationships based on findings for medium-dose groups on TC and TG.

Strengths

• Includes ten randomized controlled trials, providing a quantitative synthesis.
• Analysis includes specific statistical results (e.g., MD = 0.14 for HDL, I2 = 81.06%).
• Performs subgroup analyses by age and dose, revealing specific therapeutic windows.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The primary data file is a DOCX document, which may require extraction for quantitative analysis.

Provenance

Source

figshare admin karger

Collection Method

Meta-analysis pooling mean differences using random-effects models from searches of PubMed, Wanfang, and CNKI.

Time Range

Literature search up to December 31, 2024.

Freshness

Last updated 2026-05-08 07:55:09; freshness should be verified.